LAT4 drives temozolomide induced radiotherapy resistance in glioblastoma by enhancing mTOR pathway activation

Related articles

1. RFC4 Drives Temozolomide Resistance in Glioblastoma by Activating STK38-BECN1-Dependent Autophagy

   This article has 9 authors:

   1. Yan Wang
   2. Min Mao
   3. Ji Hang
   4. Wenqian Yu
   5. Qu-Jing Gai
   6. Sen-lin Xu
   7. Meng-Li Zhu
   8. Xi He
   9. Xin Wang

2. FOXM1 targeting alters AURKB activity and reshapes antitumor immunity to curb the progression of small cell lung cancer

   This article has 19 authors:

   1. Md Arafat Khan
   2. Parvez Khan
   3. Mahek Fatima
   4. Asad Ur Rehman
   5. Laiba Anwar
   6. Zahraa Wajih Alsafwani
   7. Aatiya Ahmad
   8. Mohammad Ali Abbas Zaidi
   9. Jesse L. Cox
   10. Areem Zahid
   11. Sameer Mohiuddin
   12. Sung Hoon Kim
   13. Juan A Santamaria-Barria
   14. Imayavaramban Lakshmanan
   15. Benita S Katzenellenbogen
   16. John A. Katzenellenbogen
   17. Apar K Ganti
   18. Surinder K Batra
   19. Mohd Wasim Nasser

3. Integrated genetic screening reveals FEN1 as a driver of stemness and temozolomide resistance in glioblastoma

   This article has 23 authors:

   1. Benjamin A. Brakel
   2. Dillon McKenna
   3. Anish Puri
   4. Vaseem Muhammad Shaikh
   5. Manoj Singh
   6. Ali Saleh
   7. Abdo-jose Tomajian
   8. Nicholas Mikolajewicz
   9. Marcello Beltrami
   10. Alisha Anand
   11. Petar Miletic
   12. Kevin R. Brown
   13. David Tieu
   14. William Maich
   15. Sabra Salim
   16. Yujin Suk
   17. Minomi Subapanditha
   18. Deena M.A. Gendoo
   19. Chitra Venugopal
   20. Jason Moffat
   21. Sachin Katyal
   22. Chirayu R. Chokshi
   23. Sheila K. Singh